| Gene symbol | CDH17 | Synonyms | CDH16, HPT-1, HPT1 | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8q22.1 | dbXrefs | |
| Description | cadherin 17 | ||||
| GTO ID | GTC3598 |
| Trial ID | NCT06055439 |
| Disease | Neuroendocrine Tumor | Colorectal Cancer | Gastric Cancer |
| Altered gene | CDH17 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CHM-2101 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 (CDH17) Chimeric Antigen Receptor (CAR) T Cell Therapy for the Treatment of Relapsed or Refractory Gastrointestinal Cancers |
| Year | 2024 |
| Country | United States |
| Company sponsor | Chimeric Therapeutics |
| Other ID(s) | CHM-2101-001 |
| Cohort 1 | |||||||||||
|
|||||||||||